Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Title
Intervention Indication Therapeutic Area Year Actions
Rezafungin for previously untreated invasive candidiasis Rezafungin (CD101) Invasive candidasis Haematology , Infectious Disease 2022 View  |  Download
Relugolix for treating advanced hormone-sensitive prostate cancer Relugolix (TAK-385) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
REGN5458 for relapsed or refractory multiple myeloma REGN5458 Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
Ravulizumab for treatment of neuromyelitis optica spectrum disorder Ravulizumab (ALXN1210; Ultomiris) Neuromyelitis optica spectrum disorders Nephrology , Ophthalmology 2022 View  |  Download
Ravulizumab (subcutaneous formulation) for treating paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) , Paroxysmal nocturnal haemoglobinuria (PNH) Haematology , Nephrology 2022 View  |  Download
Ranibizumab port delivery system for treating
diabetic macular oedema
Ranibizumab (Lucentis Port Delivery System; Lucentis) Diabetic macular oedema Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2022 View  |  Download
Potassium citrate-potassium bicarbonate prolonged release granules for treating cystinuria Potassium citrate-potassium bicarbonate Cystinuria Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Nephrology 2022 View  |  Download
Pemigatinib for treating myeloproliferative neoplasms with FGFR1 rearrangement Pemigatinib (INCB054828) Myeloproliferative Neoplasms Haematological Cancer and Lymphomas 2022 View  |  Download
Pembrolizumab with stereotactic body radiotherapy for unresected stage I or II non-small cell lung cancer Pembrolizumab (Keytruda; MK-3475) , Stereotactic body radiotherapy Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Pembrolizumab with lenvatinib for previously treated metastatic colorectal cancer Lenvatinib (Kisplyx; E7080; lenvatinib mesilate) , Pembrolizumab (Keytruda; MK-3475) Colorectal cancer Gastroenterology , Oncology 2022 View  |  Download
1 2 4 5 6 7 8 19 20
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications